Accounting for more than 16,000 cases each year, pancreatic cancer stands as the fourth most frequent cancer in France, according to reporting by courrier-picard.fr.
Medical specialists note that 80 percent of diagnoses occur at an advanced stage, leaving the disease with an 11 percent five-year survival rate, as detailed by sudouest.fr.
Ahead of World Pancreatic Cancer Day on November 19, the Léon Bérard anti-cancer center in Lyon published a list of nine clinical warning signs intended to prompt early medical consultation, as reported by lindependant.fr. While the disease predominantly affects individuals over 70 years old, case numbers are rising among younger adults aged 20 to 39, according to Courrier Picard.
Because the pancreas sits deep within the abdomen, early symptoms rarely appear distinct. Tumors can compress the bile duct and prevent normal bile drainage, causing bile to back up and bilirubin to enter the bloodstream, resulting in jaundice.
Abdominal discomfort occurs when a mass exerts pressure on neighboring organs and tissues. Similarly, pain radiating to the middle of the back develops when the deep-seated tumor irritates nearby spinal nerves.

Recent-onset diabetes can signal pancreatic disruption because the disease impairs the organ’s insulin production and elevates blood sugar levels. Tumors also promote hypercoagulation, raising the risk of thrombosis marked by leg pain, swelling, redness, or warmth.
Enzyme production disorders lead to steatorrhea, characterized by numerous greasy stools and generalized bowel transit modifications. These same digestive enzyme disruptions cause unexplained weight loss due to poor fat absorption, as noted by sudouest.fr.
Compression of the duodenum or delayed stomach emptying triggers persistent nausea and vomiting. Finally, biological and inflammatory shifts caused by the tumor alter brain function and mood, compounded by the physical and psychological toll of the illness.
Between 1998 and 2017, French health data recorded a 4.3 percent increase in pancreatic cancer cases among women and a 5.3 percent increase among men. Projections indicate that without new therapeutic strategies, the disease will become the second leading cause of cancer mortality in Europe and the United States by 2030, driven by modern Western lifestyles, rising obesity, type 2 diabetes, increased smoking among women, and consumption of ultra-processed foods.
| Metric | Statistic | Source |
|---|---|---|
| Annual Cases | More than 16,000 cases | courrier-picard.fr |
| Advanced Diagnoses | 80 percent | sudouest.fr |
| Five-Year Survival | 11 percent | sudouest.fr |
The disease lacks distinct clinical signs in its early stages, and the pancreas is located deep inside the abdomen near the spine, allowing tumors to grow undetected before pressing on adjacent nerves or organs.
While the illness primarily affects individuals older than 70, French data shows an upward trend among younger adults, specifically those aged 20 to 39.
The Léon Bérard anti-cancer center in Lyon traces its origins to 1923, when surgeon and oncologist Léon Eugène Bérard assumed leadership of the city’s cancer centre.
A pioneer in radiotherapy, he was among the first physicians to use radium to treat cancers of the buccal mucosa and cervix. The institution was later renamed in his honor following his tenure as director, which lasted until 1940. Today, it operates as an academic centre dedicated to cancer care, research, and education.
Public health authorities attribute the rising incidence to Western lifestyle factors, including growing rates of obesity, type 2 diabetes, increased smoking among women, and diets high in ultra-processed foods.